OpenHDI · Open Health Data Impact

Author Correction: Tocilizumab versus sarilumab among adults hospitalised with COVID-19: target trial emulation across England and Scotland.

Research paper from Europe PMC. Evidence status: source reported.

Published
2026-11-04
Source reference
MED:42982869
DOI
10.1038/s41467-026-78874-2
Jurisdiction
Not assessed
Licence
Bibliographic metadata only; article rights retained

Zheng B, Kurdi A, Amstutz A, Green A, Herrett E, Tazare J, Wen Q, Mahalingasivam V, Smith R, MacKenna B, Mehrkar A, Bacon S, Goldacre B, Robertson C, Sheikh A, Tomlinson L, OpenSAFELY Collaborative. · Nat Commun · published erratum; correction · Found via: OpenSAFELY

Source: https://europepmc.org/article/MED/42982869. Captured 2026-11-18.

Limitations: Discovered through a Europe PMC keyword search for OpenSAFELY. A mention is not a verified link to an access authorisation, project, dataset or clinical outcome. Preprints may not be peer reviewed.